期刊文献+

Skp2表达对食管癌术后复发及预后的影响

Effects of Skp2 overexpression on postoperative recurrence and prognosis in patients with esophageal cancer
原文传递
导出
摘要 目的研究Skp2表达对食管癌术后复发及预后的影响。方法对74例食管癌手术切除患者的病理标本进行Skp2免疫组化染色,并收集术后完整临床资料及随访资料,进行统计学分析。应用Cox比例风险模型对可能影响食管癌预后的因素进行分析,用Log-rank检验分析Skp2对总生存期(OS)、无肿瘤生存期(DFS)、局部无复发生存期(LRFS)及远处无复发生存期(DMFS)的影响。结果食管癌组织中Skp2的阳性表达率为47.3%。Skp2表达阴性患者的3年及5年生存率显著高于Skp2表达阳性患者,差异有统计学意义(P<0.01)。在食管癌组织中Skp2的表达与肿瘤的大小、淋巴结转移、浸润深度、TNM分期有关(P均<0.01)。Skp2高表达食管癌患者术后OS、DSF、DMSF及LRFS显著低于Skp2低表达患者(P<0.05)。Cox多因素回归分析表明,TNM分期、肿瘤浸润深度、有无淋巴结转移、Skp2表达是食管癌患者生存的独立预测因素。结论 Skp2过表达是食管癌术后预后不良的重要因素。 Objective To study the effects of Skp2 overexpression on the postoperative recurrence and prognosis of esophageal cancer. Methods The pathological specimens of 74 patients with surgical resection of esophageal cancer were used for Skp2 immunohistochemical staining. In addition,complete postoperative clinical information and follow-up data were collected for statistical analysis. The parameters that might influence the prognosis results of esophageal cancer were analyzed using the Cox proportional hazards model. The effects of Skp2 on overall survival( OS),disease-free survival( DFS),local recurrence-free survival( LRFS),and distant metastasis-free survival( DMFS) were analyzed using the Log-rank test. Results The positive Skp2 expression rate in esophageal cancer tissues was 47. 3 %. The 3-year and 5-year survival rate of the patients with negative Skp2 expression were significantly higher than those in patients with positive Skp2 expression. Skp2 expression was associated with lymph node metastasis,infiltration depth,and TNM staging of esophageal cancer( P〈0. 01). The results of the multivariate Cox regression analysis showed that TNM staging, tumor infiltration depth, lymph node metastasis, and Skp2 expression were independent predictors for the survival of esophageal cancer patients. The postoperative OS,DSF,DMSF,and LRFS rates of the patients with high levels of Skp2 expression were significantly worse than those with low levels of Skp2 expression. Conclusions Skp2 overexpression is an important factor of a poor postoperative prognosis of esophageal cancer.
出处 《实用老年医学》 CAS 2015年第11期948-951,共4页 Practical Geriatrics
基金 南京市医学科技发展项目(YKK11183)
关键词 食管癌 SKP2 食管癌切除术 免疫组化染色 esophageal cancer Skp2 esophagectomy for esophageal cancer immunohistochemical staining
  • 相关文献

参考文献16

  • 1Yang L, Parkin DM, Li L, et al. Time trends in cancer mortality in China: 1987-1999[J]. Int J Cancer,2003,106 (5) : 771-783.
  • 2Lee SJ, Lee KS, Yim Y J, et al. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage [ J ]. Clin Radiol, 2005, 60 ( 5 ) : 547-554.
  • 3Hershko DD. Oncogenie properties and prognostic implications of the ubiquitin ligase Skp2 in cancer [ J ]. Cancer,2008,112(7) : 1415-1424.
  • 4罗四维,彭先兵,张群,张端莲.Skp2结构与肿瘤关系研究进展[J].中华实用诊断与治疗杂志,2010,24(2):110-112. 被引量:8
  • 5Ping W, Sun W, Zu Y, et o,1. Cliaicopathological and prognostic significance of hypoxia-indueible factor-lot in e- sophageal squamous cell carcinoma: a meta-analysis [ J ]. Tumour Biol,2014,35(5) :4401-4409.
  • 6Shiozaki A, Nakashima S, Ichikawa D, et al. Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma [ J]. Anticancer Res, 2013, 33 (10) :4329-4335.
  • 7Tong Q,Zhang W,Jin S, et al.The relationship between p27 (kipl) expression and the change of radiosensitivity of e- sophageal carcinoma cells[ J]. Scand J Gastroenterol, 2011,46(2) : 173-176.
  • 8Bhattaeharya S, Garriga J, Calb6 J, et al.SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells [ J ].Oncogene, 2003,22 (16) : 2443-2451.
  • 9Tomiatti V, Istwinffy R, Pietschmann E, et al. Cksl is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors [ J ]. Oncogene,2015,34(33) :4347-4357.
  • 10Huang HY, Kang HY, Li CF, et al. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas [ J ]. Clin Cancer Res, 2006, 12 (2) :487-498.

二级参考文献28

  • 1胡洁,齐义新,王秀荣.Skp2与p27^(kip1)在乳腺癌组织中的表达及临床意义[J].河北医科大学学报,2006,27(1):26-27. 被引量:3
  • 2胡少辉,张志伟,陈孝平.P27、SKP2在肝细胞肝癌中的表达及相关性研究[J].华中医学杂志,2005,29(5):390-391. 被引量:2
  • 3王轶,魏莲枝.Skp2蛋白在喉鳞状细胞癌中的表达及其与p27蛋白表达的关系[J].川北医学院学报,2006,21(2):163-165. 被引量:3
  • 4Schifer D, Cavala P between p27/Kip. I Fiano V, et al. Inverse relationship and the F box protein Skp2 in human astrocytic gllomas by immunohistochemistry and western blot[J].NeursciLett,2002,328(2):125-128.
  • 5Zhang H, Kabayashi R, Galakitionov K, et al. plgSkp 1 and p45Skp2 are essential elements of the cyclinA-CDK2 S phase kinase[J].Cell,1995,82(6):915- 925.
  • 6Wang W, Ungermannova D, Jin J P, et al. Negative regulation of SCF-Skp2 ubiquitin ligase by TGF-beta signaling[J].Cell Bio, 2003,168(1) :55-66.
  • 7Kudo Y, Kitajima S, Ogawa I, et al. Small interfering RNA targeting of S phase kinase interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation[J]. Mol Cancer Ther,2005,4( 3 ) ;471-476.
  • 8Kamata Y, Watanabe J, Nishimura Y, et al. High expression of Skp2 correlates with poor prognosis in endometrioid adenoearcinoma[J]. J Cancer Res Clin Oncol,2005,131(9) : 591- 596.
  • 9Kim S Y, Herbst A, Tworkowski K A, et al. Skp2 regulates Myc protein stability and activity[J]. Molecular Cell, 2003, 11 (5): 1177-1188.
  • 10Hsieh F F, Barnett L A, Green W F, et al. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip 1) and inactivation of cdk2 kinase[J]. Blood,2000,96(8) :2746-2754.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部